Amylin, a 37-amino acid peptide structurally related to calcitonin gen
e-related peptide, is synthesized in and released along with insulin f
rom pancreatic beta-cells. Amylin is proposed to act as an endocrine p
artner to insulin, in part through actions upon skeletal muscle that p
romote cycling of gluconeogenic precursors to liver. We report here th
at binding sites with high affinity (K(d) = 27 pm) for radioiodinated
rat amylin are present in the nucleus accumbens region of rat brain. C
ompetition experiments show that sites measured in nucleus accumbens m
embranes have high affinity for rat amylin, lower affinity for rat cal
citonin gene-related peptides, and very low affinity for rat calcitoni
n. In contrast to rat calcitonin, salmon calcitonin has a high affinit
y for these sites, indicating that it shares critical binding determin
ants with amylin. We further tested whether salmon calcitonin shares w
ith amylin the ability to regulate glycogen metabolism in rat skeletal
muscle. Salmon calcitonin potently inhibits insulin-stimulated glucos
e incorporation into rat soleus muscle glycogen, suggesting that rat s
keletal muscle may also contain receptor populations that have high af
finity for both amylin and salmon calcitonin.